Immune response and safety of inactivated SARS-CoV-2 vaccines during pregnancy: a real-world observational study

CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study

(2022) Enny S. Paixao et al.   BMC Medicine

Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine

(2022) Edson D. Moreira et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar

(2022) Laith J. Abu-Raddad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study

(2022) Manish Sadarangani et al.   LANCET INFECTIOUS DISEASES

Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study

(2021) Kathryn J. Gray et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

(2021) Ai-ris Y. Collier et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

(2021) Tom T. Shimabukuro et al.   NEW ENGLAND JOURNAL OF MEDICINE

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection

(2021) José Villar et al.   JAMA Pediatrics

Impact of the Delta variant on vaccine efficacy and response strategies

(2021) Lianlian Bian et al.   Expert Review of Vaccines

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

(2021) Mine Durusu Tanriover et al.   LANCET

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

(2021) Alejandro Jara et al.   NEW ENGLAND JOURNAL OF MEDICINE

Short‐term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID ‐19 vaccine

(2021) S. Bookstein Peretz et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study

(2021) Po Ying Chia et al.   CLINICAL MICROBIOLOGY AND INFECTION

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

(2021) Gang Zeng et al.   LANCET INFECTIOUS DISEASES

Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery

(2021) Yawei J. Yang et al.   OBSTETRICS AND GYNECOLOGY

Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days

(2021) Qiu-Yan Xu et al.   Frontiers in Immunology

Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection

(2020) Kai Wang et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

(2020) Kizzmekia S. Corbett et al.   NEW ENGLAND JOURNAL OF MEDICINE

Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020

(2020) Sascha Ellington et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis

(2020) John Allotey et al.   BMJ-British Medical Journal

Maternal Immunological Adaptation During Normal Pregnancy

(2020) Bahaa Abu-Raya et al.   Frontiers in Immunology

SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics — Eight U.S. Health Care Centers, March 1–May 30, 2020

(2020) Lakshmi Panagiotakopoulos et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

(2020) Yanjun Zhang et al.   LANCET INFECTIOUS DISEASES

Complementemia in pregnancies with antiphospholipid syndrome

(2019) S Tabacco et al.   LUPUS

Correlates of Protection Induced by Vaccination

(2010) S. A. Plotkin   Clinical and Vaccine Immunology